A Study of Two Different Formulations of LY3502970 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The main purpose of this study is to conduct blood tests to measure how much LY3502970 is in the bloodstream when administered as two different formulations in healthy participants. The study will also evaluate the safety and tolerability of LY3502970. The study will last up to 13 weeks excluding the screening period.
Epistemonikos ID: 55a4498238616ec4ebd72add21ae41acd48c5e5a
First added on: May 13, 2024